KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Cost of Revenue: 2009-2025

Historic Cost of Revenue for Exact Sciences (EXAS) over the last 16 years, with Sep 2025 value amounting to $266.8 million.

  • Exact Sciences' Cost of Revenue rose 21.13% to $266.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.25%. This contributed to the annual value of $894.1 million for FY2024, which is 8.01% up from last year.
  • Latest data reveals that Exact Sciences reported Cost of Revenue of $266.8 million as of Q3 2025, which was up 7.31% from $248.6 million recorded in Q2 2025.
  • Exact Sciences' Cost of Revenue's 5-year high stood at $293.8 million during Q4 2022, with a 5-year trough of $119.1 million in Q4 2021.
  • In the last 3 years, Exact Sciences' Cost of Revenue had a median value of $217.8 million in 2024 and averaged $227.4 million.
  • In the last 5 years, Exact Sciences' Cost of Revenue surged by 150.12% in 2021 and then dropped by 26.29% in 2023.
  • Exact Sciences' Cost of Revenue (Quarterly) stood at $119.1 million in 2021, then skyrocketed by 146.81% to $293.8 million in 2022, then dropped by 26.29% to $216.6 million in 2023, then rose by 12.90% to $244.5 million in 2024, then climbed by 21.13% to $266.8 million in 2025.
  • Its Cost of Revenue stands at $266.8 million for Q3 2025, versus $248.6 million for Q2 2025 and $264.3 million for Q1 2025.